trending Market Intelligence /marketintelligence/en/news-insights/trending/k_fxluqe1xq43ezypdpz8a2 content esgSubNav
In This List

Sienna Cancer Diagnostics adds board director

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Sienna Cancer Diagnostics adds board director

Sienna Cancer Diagnostics Ltd. named Helen Fisher an independent nonexecutive director, effective March 28.

Fisher will also act as chair of the company's audit and risk committee. She was a partner at Deloitte and adviser to several life sciences and biotechnology companies, Sienna Cancer Diagnostics said in a news release.

Australia-based Sienna Cancer is a medical technology company developing and marketing innovative cancer related tests, with operations in the U.S. and Europe.